Clinical trials
Observational Vascular Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Universitari de Bellvitge | 2 |
| Phenox GmbH | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Ain Shams University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beijing Hospital of Traditional Chinese Medicine | 1 |
| Beni-Suef University | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Cardiff and Vale University Health Board | 1 |
| Cardiocentro Ticino | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vascular Diseases | 53 |
| Cardiovascular Diseases | 17 |
| Heart Diseases | 12 |
| Coronary Artery Disease | 6 |
| Myocardial Ischemia | 6 |
| Coronary Disease | 5 |
| Stroke | 5 |
| Arterial Occlusive Diseases | 4 |
| Arteriosclerosis | 4 |
| Atherosclerosis | 4 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.